Colorectal Cancer Biomarkers

Biomarkers can help a treatment team to determine the best treatment for a patient, see how the patient is responding, and assist in creating a care plan. New tumor markers are being identified with more frequency, so all tumor markers may not yet be reflected on this list.

  • ABCBG
  • Cadherin-17 (CDH-17)
  • Calretinin-
  • CA 11-19
  • CA 72-4
  • CD 166
  • CDC25B Phosphatase
  • CEA
  • CK20 (Cytokeratin 20) and CK7 (Cytokeratin 7) CK18, CK20
  • COX2
  • ctDNA
  • BRAF V600 mutations
  • DPYD
  •  Ezrin
  •  GPA33
  • HER2 gene amplification or overexpression
  • HMGB1
  • Insulin-like growth factor binding protein 2 (IGFBP2)
  • Ki67
  • KRAS
  • Microsatellite instability (MSI) and/or mismatch repair deficient (dMMR) 
  • miR141
  • MOC-31/Ep-CAM
  • MUC2
  • NRAS
  • NTRK gene fusion
  • Nucleosome
  • P53
  • PIK3CA
  • PKM2
  • Programmed death ligand 1 (PD-L1)
  • Sidedness
  • VEGF
  • VIllin